Indeed, when re-challenged with tumour cells in vivo, ICI-OV treated animals were able to successfully inhibit tumour growth [75,76,79,83,84], with one study demonstrating significant reductions in tumour growth and increased survival following VV-PDL1 treatment compared to parental VV treatment [92]. This evidence concerns the gene CD274 and neoplasm.